NEWS CENTER

Start with a sprint—aim for a winning, blockbuster start! Keyuan Pharmaceutical held its Q1 2025 Marketing Meeting, rallying the entire team to powerfully drive and achieve breakthrough marketing targets!

Publish Time:

2025-03-23

On the 22nd, Keyuan Pharmaceutical successfully held its Q1 2025 Marketing Conference, themed "Embrace Productism, Focus on Precision Cultivation, Deeply Unlock Potential, Foster Systemic Collaboration, and Deliver Targeted Empowerment—Uniting All Employees to Drive Marketing Targets Toward Breakthrough Success." The meeting provided a comprehensive review of the company's Q1 marketing achievements and outlined the sales objectives for the second quarter. Senior company leaders, the sales team, and heads of various functional departments gathered together to collaboratively explore strategies for achieving and surpassing this year's marketing targets.

At the meeting, each sales region reported on their first-quarter performance against key targets, summarizing both the outstanding practices and the areas where improvements were needed. By conducting precise market analysis and deeply understanding customer needs, the regional sales teams refined their product promotion strategies, resulting in a significant boost in customer satisfaction during the first quarter. In response to certain challenges encountered in the first quarter, the meeting outlined specific improvement measures, including strengthening market research, optimizing sales strategies, and enhancing customer satisfaction—actions designed to build momentum for achieving goals not only in the second quarter but also throughout the year, ultimately paving the way for even greater breakthroughs.

The meeting emphasized that long-termism, product-centricity, altruism, and a global strategy are Core Pharmaceutical’s core business principles. The company should continue to make sustained, long-term investments, firmly advance its internationalization strategy, and gradually achieve comprehensive expansion into overseas markets. 2025 is a pivotal year for Core Pharmaceutical to realize leapfrog growth. The company will remain profit-driven, leverage budget management as a key tool, prioritize sales as the driving force, rely on R&D as its engine of innovation, and ensure everything through a robust operational system—working tirelessly to meet and exceed its annual targets.

The meeting emphasized that all functional departments should fully support marketing efforts within their respective areas of responsibility. The production department should strengthen backend support for marketing by reducing costs, improving efficiency, and enhancing product quality. Meanwhile, the R&D team must accelerate the development and launch of new products, ensuring that the product portfolio meets market demands. The finance department is tasked with tightly controlling costs and optimizing budget management to guarantee the efficient allocation of funds. Additionally, the quality control team must maintain consistent product quality, ultimately boosting customer satisfaction. Lastly, the supply chain department should streamline procurement and logistics processes to ensure timely product delivery. All departments are encouraged to collaborate closely, break down internal barriers, and work together synergistically—leveraging the collective strength of every team member—to effectively drive marketing initiatives and ensure the company achieves its overarching goals smoothly.

The meeting clearly outlined the sales tasks and objectives for the second quarter, explored strategies and pathways to achieve these goals, and emphasized the need for cross-departmental collaboration to ensure breakthroughs and successful attainment of marketing targets. As the vast ocean gathers rivers, the favorable winds are just right for unfurling our sails. All employees at Keyuan Pharmaceutical will seize this opportunity to maintain our relentless "start with full speed" spirit, giving our all to conquer this year’s ambitious goals and ensuring the smooth achievement of our 2025 annual targets!

Continuously advancing the internationalization strategy (Series 4) | Keyuan Pharmaceutical showcases at Japan International Pharmaceutical Raw Materials Exhibition and the European Cosmetics Ingredients Expo (Netherlands)!

Protecting Investors: Keyuan in Action | Stay Away from Illegal Stock Recommendations, Refuse Off-Exchange Margin Financing